CIRM funds $25 million for Geron trial, $38 million for basic biology
CIRM announced two sets of awards today that both should make major impact including its first clinical trial via Geron and $38 million for 27 basic biology studies. First Clinical Trial. Today CIRM awarded $25 million to support Geron’s FDA-approved clinical trial for spinal cord injury. This is CIRM’s first award to a for-profit company …
CIRM funds $25 million for Geron trial, $38 million for basic biology Read More »